AVAI BIO, INC.

AVAI BIO, INC. is a technology company focused on acquiring, creating, and developing advanced technologies that utilize artificial intelligence (AI), and providing information technology consulting services. The company considers itself an expert in AI-based information technology. Key acquisitions include Avant! AI and a Joint Venture and License Agreement with Ainnova Tech Inc. These acquisitions provide resources in full-stack software development, database management, data integration, project management, and cloud services. AVAI BIO, INC. aims to provide AI solutions that transform businesses. Its technology is designed to offer a self-sustained system that prepares data from unlabeled information using Unsupervised Clustering. This data is then analyzed using various proprietary supervised learning techniques to improve data efficiency. Unsupervised learning pre-processes and extracts meaningful features from raw or unlabeled data, preparing them as inputs for the supervised learning model. This process facilitates learning from experience by utilizing unsupervised learning to learn relevant information from many source domains. This knowledge is then evaluated and applied to related or different domains where information might be limited, representing a true learning capability. The company leverages knowledge learned from source domains to improve performance in other domains and for factual discovery and conclusions by learning data. Its unsupervised learning techniques, such as clustering, identify groups or patterns in data to reach conclusions. Subsequently, its supervised learning mechanism creates new datasets, which are used for further domains, improving classification and regression tasks. This feature is described as a true reasoning mechanism. On February 3, 2026, the company changed its corporate name from Avant Technologies, Inc. to Avaí Bio, Inc.